RAPT Therapeutics (RAPT) Accumulated Depreciation & Amortization: 2020-2024
Historic Accumulated Depreciation & Amortization for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $9.8 million.
- Therapeutics' Accumulated Depreciation & Amortization rose 8.04% to $9.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $38.4 million, marking a year-over-year increase of 11.02%. This contributed to the annual value of $9.4 million for FY2023, which is 13.55% up from last year.
- Per Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $9.8 million for Q3 2024, which was up 2.28% from $9.6 million recorded in Q2 2024.
- Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $9.8 million for Q3 2024, and its period low was $6.3 million during Q1 2020.
- Over the past 3 years, Therapeutics' median Accumulated Depreciation & Amortization value was $8.7 million (recorded in 2023), while the average stood at $8.8 million.
- Data for Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY climbed of 17.64% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Therapeutics' Accumulated Depreciation & Amortization stood at $7.1 million in 2020, then rose by 8.50% to $7.7 million in 2021, then increased by 7.35% to $8.2 million in 2022, then increased by 13.55% to $9.4 million in 2023, then increased by 8.04% to $9.8 million in 2024.
- Its Accumulated Depreciation & Amortization stands at $9.8 million for Q3 2024, versus $9.6 million for Q2 2024 and $9.7 million for Q1 2024.